Diffuse alveolar hemorrhage syndrome in children: Primary immunodeficiency diseases and implications for clinical
Xiaoyan Zhang1, Hui Liu1, Xiaolei Tang1
1Department of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Insights
Primary immunodeficiency diseases (PIDs) are increasingly recognized as a significant cause of diffuse alveolar hemorrhage (DAH) in children. Genetic diagnosis is crucial for identifying PIDs and guiding effective, genotype-specific treatment strategies.
Area of Science:
- Pediatric Pulmonology
- Clinical Immunology
- Medical Genetics
Background:
- Primary immunodeficiency diseases (PIDs) are emerging causes of diffuse alveolar hemorrhage (DAH) in children.
- Literature on PID-associated DAH is limited, necessitating increased awareness.
- Genetic advancements aid in identifying PIDs as underlying causes of pediatric DAH.
Purpose of the Study:
- To enhance awareness of PIDs as causes of pediatric DAH.
- To evaluate the implications of genetic diagnosis for treating PID-associated DAH.
- To assess the prevalence and clinical characteristics of PID-associated DAH in a pediatric cohort.
Main Methods:
- Retrospective analysis of 68 children with DAH who underwent genetic testing.
- Examination of clinical findings, genetic results, and treatment outcomes.
- Focus on pediatric respiratory ward patients over a 10-year period.
Main Results:
- 16 out of 68 children (23.5%) were diagnosed with PIDs.
- Genetic testing identified 10 different immunity-defective genes in 14 patients.
- DAH was the primary manifestation in all pediatric PID cases; 87.5% achieved remission with genotype-specific treatment.
Conclusions:
- PIDs are a significant cause of DAH in children.
- Identifying PIDs and causal variants allows for genotype-specific treatment.
- Genetic diagnosis provides critical guidance for managing pediatric DAH.
Background:
With the advances in genetic diagnosis in the past decade, primary immunodeficiency diseases (PIDs) have been increasingly identified as emerging causes of (DAH) among children treated in our department. The literature regarding PID-associated DAH are limited. Thus, we aim to enhance the awareness that PIDs can be underlying causes of pediatric DAH and evaluate the implications of genetic diagnosis for treatment.
Methods:
This analysis included 68 children with DAH who had undergone genetic tests in the pediatric respiratory ward during the preceding 10 years. Their clinical findings, genetic results, and treatment were retrospectively examined.
Results:
In total, 16 children were diagnosed with PIDs. Genetic diagnoses of PIDs yielded in 14 patients revealed involvement of 10 immunity-defective genes (TNFRSF13B, TCF3, NFKB2, PIK3CD, COPA, ADA2, PLCG2, RAG1, BCL11B, and STAT3). The remaining two children had diagnoses of CVID without associated variants. The overall prevalence of PID-associated DAH in our cohort was 23.5% (16/68). The median age at DAH symptom onset was 3.5 (interquartile range: 2.1-9.3) years. In all children, DAH is the primary or even initial clinical manifestation of the PIDs. Of the children, 37.5% (6/16) developed additional autoimmune or inflammatory complications. 50% (8/16) of patients adjusted their therapeutic management according to the genetic diagnosis. 87.5% (14/16) of patients achieved remission.
Conclusion:
This study suggests that PID is one of the most important causes of DAH in children. The identification of the PIDs and the causal variants enables genotype-specific treatment, which may offer critical guidance for clinical management.
More Related Videos
Related Concept Videos
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency...
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:36Humoral Immune Responses
01:21Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: